Qiming Venture Partners USA is a Cambridge, Massachusetts-based venture capital firm focused on early-stage healthcare investing in the United States and Europe. It backs therapeutics, biotechnology, life sciences, pharmaceuticals, medical devices and healthtech companies, including seed, Series A and Series B rounds. The firm has acted as a lead or co-lead investor and provides companies with financial and human capital, including access to the broader Qiming network for diligence, deal flow and operational support.